MAYNE PHARMA GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.28 AUD | -2.28% |
|
-9.13% | -30.41% |
| 07-02 | Australian Shares Slide as Central Bank Shows Signs of Possible Rate Hike | MT |
| 06-03 | Swissmedic Grants Mayne Pharma Group Expanded Kapanol Dosage Approvals in Switzerland | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 240M | - | |||||
| 45.07B | ||||||
| 23.39B | ||||||
| 16.08B | ||||||
| 14.6B | ||||||
| 14.01B |
